Loading...
Efficacy of atovaquone on EpCAM(+)CD44(+) HCT-116 human colon cancer stem cells under hypoxia
Tumor hypoxia contributes to the development of resistance to chemotherapeutic drugs in several human cancer cell lines. Atovaquone, an anti-malaria drug approved by the US Food and Drug Administration, has recently demonstrated anti-cancer effects in vitro and in vivo in several cancer models. To a...
Na minha lista:
| Udgivet i: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7668131/ https://ncbi.nlm.nih.gov/pubmed/33209130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9416 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|